Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07528300

Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis

Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Rhabdomyolysis Agnosia Muscular Diseases Musculoskeletal Diseases Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pathological Conditions, Signs and Symptoms Perceptual Disorders Signs and Symptoms

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tripler Army Medical Center

TAMC, Hawaii, 96859, United States

Location status: Recruiting

Location contact

Susan A Scrivner, BS

CONTACT

[email protected]

808-433-5486

About this study

Pilot study using a prospective observational case series of patients admitted to Tripler Army Medical Center who meet CHAMP criteria for rhabdomyolysis and who elect to undergo BFA in addition to standard of care pain control. We will not blind patients, providers, or research coordinators. Goal is to administer BFA within 12 hours of inpatient admission and monitor the pain response.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Rhabdomyolysis
  • chooses battlefield acupuncture

Exclusion criteria

  • Greater than 72 hours from onset of symptoms
  • younger than 18 years of age
  • declines battlefield acupuncture
  • no pain

Treatment and study plan

Battlefield Acupuncture

Procedure

Treatment of pain from rhabdomyolysis with battlefield acupuncture

Primary outcomes

  1. Pain Level on a pain scale of 0-10

    Time frame: Pain level will be measured through study completion (up to 12 months).

    Reported pain levels on a subjective pain score of 0-10

  2. Pain Medication

    Time frame: From enrollment to the end of treatment at 12 months

    Amount of pain medication required, Morphine equivalent and acetaminophen use on hospital days 1-7

Secondary outcomes

  1. Length of Hospital Stay in days

    Time frame: Length of time from admission to discharge in days (up to 7 days)

    How long the patient stays in the hospital in days

Study contacts

Contact information is provided by the study sponsor or research team.

Chelsea W Tagawa, MD

CONTACT

[email protected]

808-433-2202

Susan A Scrivner, MS

CONTACT

[email protected]

808-433-5486

Sponsors and collaborators

Lead sponsor

Tripler Army Medical Center

Fed

Registry information

Important dates

Study start
2023
Primary completion
2028
Study completion
2028
First posted
Apr 14, 2026
Registry last updated
Apr 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.